137 related articles for article (PubMed ID: 38520052)
1. Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2-month-old infant.
Chiba Y; Tasaka K; Matsubara K; Mori M; Muraoka M; Hamabata T; Nodomi S; Waki K
Pediatr Blood Cancer; 2024 Jun; 71(6):e30953. PubMed ID: 38520052
[No Abstract] [Full Text] [Related]
2. Treatment of chronic immune thrombocytopenia in children with romiplostim.
Chaturvedi S; McCrae KR
Lancet; 2016 Jul; 388(10039):4-6. PubMed ID: 27103125
[No Abstract] [Full Text] [Related]
3. Comment on: Use of thrombopoietin receptor agonist (romiplostim) in neonatal autoimmune thrombocytopenia due to maternal immune thrombocytopenia.
Mahat U; Talati R; Kodish E
Pediatr Blood Cancer; 2019 Jun; 66(6):e27706. PubMed ID: 30854752
[No Abstract] [Full Text] [Related]
4. Remissions after long-term use of romiplostim for immune thrombocytopenia.
Marshall AL; Scarpone R; De Greef M; Bird R; Kuter DJ
Haematologica; 2016 Dec; 101(12):e476-e478. PubMed ID: 27587382
[No Abstract] [Full Text] [Related]
5. Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.
Tsukamoto S; Nakaseko C; Takeuchi M; Kumagai K; Komatsu T; Tanaka H; Hara S; Koizumi M; Imai H; Yokota A; Takeuchi M; Inokuchi K; Matsuura Y; Aotsuka N; Wakita H
Br J Haematol; 2013 Oct; 163(2):286-9. PubMed ID: 23862773
[No Abstract] [Full Text] [Related]
6. Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura.
Gardiner EE; Thom JY; Al-Tamimi M; Hughes A; Berndt MC; Andrews RK; Baker RI
Br J Haematol; 2010 May; 149(4):625-8. PubMed ID: 20148887
[No Abstract] [Full Text] [Related]
7. Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.
Atkinson K
Clin J Oncol Nurs; 2019 Apr; 23(2):212-216. PubMed ID: 30880797
[TBL] [Abstract][Full Text] [Related]
8. Salvage therapy of autoimmune thrombocytopenic purpura revealing non-Hodgkin lymphoma by the thrombopoietin receptor agonist romiplostim.
Al-Nawakil C; Park S; Chapuis N; Dreyfus F; Szwebel TA; Gibault L; Molina T; Hermine O; Bouscary D; Tamburini J
Br J Haematol; 2012 Jan; 156(1):145-7. PubMed ID: 21848881
[No Abstract] [Full Text] [Related]
9. Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy.
Patil AS; Dotters-Katz SK; Metjian AD; James AH; Swamy GK
Obstet Gynecol; 2013 Aug; 122(2 Pt 2):483-485. PubMed ID: 23884268
[TBL] [Abstract][Full Text] [Related]
10. The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim.
Al-Samkari H; Schifferli A; Gonzalez-Lopez TJ
Br J Haematol; 2024 Apr; 204(4):1143-1145. PubMed ID: 38319005
[TBL] [Abstract][Full Text] [Related]
11. Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy.
Decroocq J; Marcellin L; Le Ray C; Willems L
Obstet Gynecol; 2014 Aug; 124(2 Pt 2 Suppl 1):481-483. PubMed ID: 25004319
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.
Magnano L; Enríquez H; Esteve J; Cervera R; Espinosa G
J Rheumatol; 2014 Sep; 41(9):1895-6. PubMed ID: 25179983
[No Abstract] [Full Text] [Related]
13. Romiplostim for management of refractory immune thrombocytopenic purpura in the immediate postpartum period.
Patras A; Figueroa R; Singh AP; Madan I
BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32430352
[TBL] [Abstract][Full Text] [Related]
14. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
15. New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients.
Yoon JS; Lee YJ; Baek DW; Park HY; Park BE; Moon JH; Sohn SK
Korean J Intern Med; 2018 Mar; 33(2):435-437. PubMed ID: 26947025
[No Abstract] [Full Text] [Related]
16. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
Mori M; Kato M; Koh K; Hanada R
Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675
[TBL] [Abstract][Full Text] [Related]
17. Plateletpheresis for postsplenectomy rebound thrombocytosis in a patient with chronic immune thrombocytopenic purpura on romiplostim.
Raval JS; Redner RL; Kiss JE
J Clin Apher; 2013 Aug; 28(4):321-4. PubMed ID: 23450778
[TBL] [Abstract][Full Text] [Related]
18. ITP, interrupted.
Stasi R
Blood; 2011 Oct; 118(16):4297-8. PubMed ID: 22021448
[No Abstract] [Full Text] [Related]
19. High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia.
Seidel MG; Urban C; Sipurzynski J; Beham-Schmid C; Lackner H; Benesch M
Br J Haematol; 2014 May; 165(3):419-21. PubMed ID: 24484542
[No Abstract] [Full Text] [Related]
20. Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):331-4. PubMed ID: 22343685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
